These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9484691)

  • 1. Fat gram target.
    Robinson P
    J Paediatr Child Health; 1997 Dec; 33(6):545. PubMed ID: 9484691
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic enzyme supplements in cystic fibrosis.
    Morrison G; Morrison J; Redmond A; Byers C; McCracken K; Dodge JA
    Lancet; 1991 Dec 21-28; 338(8782-8783):1596-7. PubMed ID: 1683999
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic enzyme supplement dosage in cystic fibrosis.
    Owen G; Peters TJ; Dawson S; Goodchild MC
    Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
    Warwick WJ; Budd JR
    Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
    Costantini D; Padoan R; Curcio L; Giunta A
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S36-9. PubMed ID: 3404360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
    Pettei MJ; Leonidas JC; Levine JJ; Gorvoy JD
    J Pediatr; 1994 Oct; 125(4):587-9. PubMed ID: 7931879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
    Henker J; Hoffmann D; Paul D; Hein J; Paditz E
    Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic enzymes and fibrosing colonopathy.
    Bakowski M
    Lancet; 1999 Jul; 354(9174):249; author reply 251. PubMed ID: 10421321
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment failure after substitution of generic pancrelipase capsules.
    Haymes AJ; Levy RA
    JAMA; 1990 Dec; 264(24):3148-9. PubMed ID: 2255022
    [No Abstract]   [Full Text] [Related]  

  • 16. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 17. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future.
    George DE; Mangos JA
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S49-57. PubMed ID: 3042940
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative management of patients with total exocrine pancreatic insufficiency.
    Braga M; Zerbi A; Dal Cin S; De Franchis R; Malesci A; Di Carlo V
    Br J Surg; 1990 Jun; 77(6):669-72. PubMed ID: 2383737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malabsorption in cystic fibrosis: mechanisms and treatment.
    Bouquet J; Sinaasappel M; Neijens HJ
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.